Back
Regeneron Pharmaceuticals Stock Price Chart
R.I.P. for the American Dream? (Surprising answer inside...)
Go here now for the details.
Buy
59
REGN
Regeneron Pharmaceuticals
Last Price:
825.08
Seasonality Move:
4.56%
7 Day Trial
ALL ACCESS PASS
$
7
Unexpected gains from AI stocks
Click here to see the proof for yourself.- The current trend is moderately bullish and REGN is experiencing slight selling pressure.
Regeneron Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 827.89 | Sell |
| 20-day SMA: | 828.56 | Sell |
| 50-day SMA: | 793.26 | Buy |
| 200-day SMA: | 766.14 | Buy |
| 8-day EMA: | 827.64 | Sell |
| 20-day EMA: | 824.04 | Buy |
| 50-day EMA: | 803.21 | Buy |
| 200-day EMA: | 762.01 | Buy |
Regeneron Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 7.66 | Buy |
| Relative Strength Index (14 RSI): | 53.72 | Buy |
| Chaikin Money Flow: | -4223 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (822.62 - 836.62) | Sell |
| Bollinger Bands (100): | (727.56 - 812.46) | Buy |
Regeneron Pharmaceuticals Technical Analysis
| Sep 11 | Sep 12 | Sep 13 | Sep 14 | Sep 15 | Sep 18 | Sep 19 | Sep 20 | Sep 21 | Sep 22 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 11 | 12 | 13 | 14 | 15 | 18 | 19 | 20 | 21 | 22 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Regeneron Pharmaceuticals Stock
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 824.84 while REGN 8-day simple moving average is 827.89, which is a Sell signal.
- The stock price of REGN is 824.84 while Regeneron Pharmaceuticals 20-day SMA is 828.56, which makes it a Sell.
- Regeneron Pharmaceuticals 50-day simple moving average is 793.26 while REGN share price is 824.84, making it a Buy technically.
- REGN stock price is 824.84 and Regeneron Pharmaceuticals 200-day simple moving average is 766.14, creating a Buy signal.
REGN Technical Analysis vs Fundamental Analysis
Buy
59
Regeneron Pharmaceuticals (REGN)
is a Buy
Is Regeneron Pharmaceuticals a Buy or a Sell?
-
Regeneron Pharmaceuticals stock is rated a Buy
The current Regeneron Pharmaceuticals [REGN] share price is $824.84. The Score for REGN is 59, which is 18% above its historic median score of 50, and infers lower risk than normal.
Regeneron Pharmaceuticals Stock Info
Market Cap:
89.54B
Price in USD:
824.84
Share Volume:
464.5K
Regeneron Pharmaceuticals 52-Week Range
52-Week High:
847.50
52-Week Low:
668.00
Buy
59
Regeneron Pharmaceuticals (REGN)
is a Buy
Regeneron Pharmaceuticals Share Price Forecast
-
What is the Regeneron Pharmaceuticals stock price today?
The Regeneron Pharmaceuticals stock price is 824.84 USD today. -
Will REGN stock go up or go down?
Regeneron Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Regeneron Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Regeneron Pharmaceuticals is not overvalued.
Is Regeneron Pharmaceuticals Stock a Buy?
- Regeneron Pharmaceuticals share price is 824.84 while REGN 8-day exponential moving average is 827.64, which is a Sell signal.
- The stock price of REGN is 824.84 while Regeneron Pharmaceuticals 20-day EMA is 824.04, which makes it a Buy.
- Regeneron Pharmaceuticals 50-day exponential moving average is 803.21 while REGN share price is 824.84, making it a Buy technically.
- REGN stock price is 824.84 and Regeneron Pharmaceuticals 200-day simple moving average is 762.01, creating a Buy signal.
Fundamental Analysis of Regeneron Pharmaceuticals
Is Regeneron Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $1.58 per share, an increase next quarter of $0.54 per share, a decrease this year of $0.50 per share, and an increase next year of $1.95 per share.
Technical Analysis of Regeneron Pharmaceuticals
Should I short Regeneron Pharmaceuticals stock?
- REGN Moving Average Covergence Divergence (MACD) indicator is 7.66, suggesting Regeneron Pharmaceuticals is a Buy
- Regeneron Pharmaceuticals Relative Strength Index (RSI) is 53.72, which suggest Regeneron Pharmaceuticals is overbought
- The Bollinger Bands (25) for Regeneron Pharmaceuticals is (822.62 - 836.62), which suggest Regeneron Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Regeneron Pharmaceuticals is (727.56 - 812.46), which suggest Regeneron Pharmaceuticals is a Buy
* Regeneron Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.